Matthew T. Garin, MD
Clinical Associate Professor of Medicine (General Internal Medicine)
Attending Physician, Corporal Michael J. Crescenz VAMC
Co-Director, Chief Resident in Quality and Safety (CRQS), Corporal Michael J. Crescenz VAMC
Deputy Chief of Staff for Patient Safety and Quality, Corporal Michael J. Crescenz VAMC
Department: Medicine
Contact information
Department of Medicine, 8th Floor
Corporal Michael J. Crescenz VAMC
Philadelphia, VA
Philadelphia, PA 19104
Corporal Michael J. Crescenz VAMC
Philadelphia, VA
Philadelphia, PA 19104
Office: 215-823-5800 x5993
Email:
matthew.garin@va.gov
matthew.garin@va.gov
Education:
BA (Biology)
Williams College, 2001.
MD
Medical University of South Carolina, 2008.
BA (Biology)
Williams College, 2001.
MD
Medical University of South Carolina, 2008.
Post-Graduate Training
Internship in Internal Medicine, Hospital of University of Pennsylvania, 2008-2009.
Residency in Internal Medicine, Hospital of University of Pennsylvania, 2009-2011.
Internship in Internal Medicine, Hospital of University of Pennsylvania, 2008-2009.
Residency in Internal Medicine, Hospital of University of Pennsylvania, 2009-2011.
Certifications
American Board of Internal Medicine, 2011.
Permanent linkAmerican Board of Internal Medicine, 2011.
Selected Publications
Umscheid CA, Wilen J, Garin M, Goldstein JD, Cook TS, Liu Y, Chen Y, Myers JS.: National Survey of Hospitalists' Experiences with Incidental Pulmonary Nodules. J Hosp Med 14: E1-E4, Feb 2019 Notes: DOI: 10.12788/jhm.3115.MT Garin, C Soran, T Cook, M Ferguson, S Day, J Myers: Lost in surveillance: Communication and follow-up of incidental lung nodules found on chest CT in a hospitalized and ambulatory patient population. Association of American Medical Colleges, Integrating Quality (IQ) Meeting. Chicago, IL. June 2015 Notes: Poster Presentation.
Matthew Garin, Christine Soran, Tessa Cook, Monica Ferguson, Susan Day, and Jennifer Myers. : Communication and follow-up of incidental lung nodules found on chest CT in a hospitalized and ambulatory patient population. Society of Hospital Medicine, Annual Meeting. San Diego, CA. April 2015 Notes: Poster Presentation.
Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ, Le Beau MM, Rowley JD, Liu PP, Wolff L. : Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16). Cancer Res 67(3): 992-1000, Feb 2007 Notes: DOI: 10.1158/0008-5472.CAN-06-2964.
Wolff L, Garin MT, Koller R, Bies J, Tessarollo L, Anver MR, Powell D, Perella C.: A novel retrovirus provides the cooperating oncogenic event(s) required to demonstrate the tumor suppressor activity of p15Ink4b in myeloid cells in vivo. Blood Cells Mol Dis 32(1): 226-31, Jan-Feb 2004.
Wolff L, Garin MT, Koller R, Bies J, Liao W, Malumbres M, Tessarollo L, Powell D, Perella C.: Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice. Oncogene 22(58): 9265-74, Dec 2003 Notes: DOI: 10.1038/sj.onc.1207092.
Opavsky R, Haviernik P, Jurkovicova D, Garin M T, Copeland N G, Gilbert D J, Jenkins N A, Bies J, Garfield S, Pastorekova S, Oue A, Wolff L: Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 276(42): 38795-807, Oct 2001 Notes: DOI: 10.1074/jbc.M105241200.